Chemical Works of Gedeon Richter Plc (RGEDF)
38.55
+0.62
(+1.64%)
USD |
OTCM |
Oct 06, 16:00
Chemical Works of Gedeon Richter Profit Margin (Quarterly) : 15.81% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.81% |
| March 31, 2026 | 29.74% |
| December 31, 2025 | 27.61% |
| September 30, 2025 | 20.23% |
| June 30, 2025 | 21.51% |
| March 31, 2025 | 30.43% |
| December 31, 2024 | 28.77% |
| September 30, 2024 | 17.12% |
| June 30, 2024 | 32.49% |
| March 31, 2024 | 33.69% |
| December 31, 2023 | 18.16% |
| September 30, 2023 | 29.01% |
| June 30, 2023 | 14.73% |
| March 31, 2023 | 18.62% |
| December 31, 2022 | -11.84% |
| September 30, 2022 | 37.73% |
| June 30, 2022 | 40.01% |
| March 31, 2022 | 22.56% |
| December 31, 2021 | 26.70% |
| September 30, 2021 | 24.43% |
| June 30, 2021 | 18.40% |
| March 31, 2021 | 19.13% |
| December 31, 2020 | 14.46% |
| September 30, 2020 | 16.71% |
| June 30, 2020 | 23.45% |
| Date | Value |
|---|---|
| March 31, 2020 | 20.58% |
| December 31, 2019 | -9.82% |
| September 30, 2019 | 17.62% |
| June 30, 2019 | 14.96% |
| March 31, 2019 | 17.79% |
| December 31, 2018 | -13.20% |
| September 30, 2018 | 9.13% |
| June 30, 2018 | 22.36% |
| March 31, 2018 | 12.49% |
| December 31, 2017 | 6.63% |
| September 30, 2017 | 14.92% |
| June 30, 2017 | 7.85% |
| March 31, 2017 | 18.47% |
| December 31, 2016 | 21.58% |
| September 30, 2016 | 15.01% |
| June 30, 2016 | 17.77% |
| March 31, 2016 | 13.16% |
| December 31, 2015 | 11.75% |
| September 30, 2015 | 7.29% |
| June 30, 2015 | 23.25% |
| March 31, 2015 | 17.11% |
| December 31, 2014 | -4.56% |
| September 30, 2014 | 6.40% |
| June 30, 2014 | 15.86% |
| March 31, 2014 | 10.67% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AstraZeneca PLC | 20.15% |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Avadel Pharmaceuticals Plc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 15.75% |
| Return on Assets | 12.87% |
| Return on Invested Capital | 15.39% |
| Gross Profit Margin (Quarterly) | 70.03% |
| Operating Margin (Quarterly) | 36.60% |
| Return on Net Operating Assets | 18.43% |